Generic name |
tezepelumab |
|
---|---|---|
Strength and form |
210 mg/1.91 mL pre-filled syringe |
Special Authority criteria |
Approval period |
---|---|
Initial For the add-on maintenance treatment of patients aged 12 yeas and older with severe asthma meeting ALL the following criteria:
OR
Note: Coverage of tezepelumab will not be provided for use in combination with other biologics for the treatment of asthma. |
1 year |
First renewal Renewal of coverage requested by a resipirologist or allergist with expertise in treating asthma1 will be considered for patients aged 12 years and older with severe asthma whose:
AND meeting one of the following:
OR
|
1 year |
Second and subsequent renewal Second and subsequent renewal of coverage must be requested by a respirologist or allergist with expertise in treating asthma1 , and will be considered for patients aged aged 12 years and older with severe asthma whose:
AND meeting one of the following:
OR
|
1 year |